Interestingly, exogenous BDNF application or treatment with an ampakine that increases BDNF expression is sufficient to restore robust LTP in homozygous knock-in HD mice (Lynch et al., 2007; Simmons et al., 2009). This evidence concerns the gene BDNF and Huntington disease.